SouthState’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.05K Hold
16
– – ﹤0.01% 1126
2026
Q2
$1.19K Hold
16
– – ﹤0.01% 1073
2026
Q1
$1.19K Hold
16
– – ﹤0.01% 1006
2025
Q4
$1.22K Hold
16
– – ﹤0.01% 1081
2025
Q3
$832 Hold
16
– – ﹤0.01% 1110
2025
Q2
$691 Sell
16
-14
-47% -$509 ﹤0.01% 1358
2025
Q1
$1.04K Buy
+30
New +$1.01K ﹤0.01% 1328

Other funds holding BBIO

SouthState's BBIO Position: Q3 2026 in Review

SouthState held its BridgeBio Pharma (BBIO) position steady in Q3 2026 at 16 shares worth $1.05K. The position accounts for ﹤0.01% of the portfolio, ranked #1126.

SouthState first reported a position in BBIO in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.22K in Q4 2025. 348 funds tracked by Wall St. Rank hold BBIO as of Q3 2026.

  • SouthState held 16 shares of BridgeBio Pharma worth $1.05K as of Q3 2026.
  • SouthState left its BridgeBio Pharma share count unchanged in Q3 2026.
  • BridgeBio Pharma made up ﹤0.01% of SouthState's portfolio in Q3 2026, its #1126 holding.
  • SouthState first reported a position in BridgeBio Pharma in Q1 2025 and has held it in 7 quarters since.
  • SouthState's BridgeBio Pharma position peaked at $1.22K in Q4 2025.
  • 348 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q3 2026.

Based on SouthState's 13F filing for Q3 2026, filed 9 Nov 2026.